you are here:

Dr Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE089A01023 | SECTOR: Pharmaceuticals

BSE Live

Aug 16, 16:01
4296.90 34.65 (0.81%)
Volume
AVERAGE VOLUME
5-Day
7,145
10-Day
29,592
30-Day
24,578
11,363
  • Prev. Close

    4262.25

  • Open Price

    4262.00

  • Bid Price (Qty.)

    4296.90 (2)

  • Offer Price (Qty.)

    4300.00 (15)

NSE Live

Aug 16, 15:58
4297.80 37.00 (0.87%)
Volume
AVERAGE VOLUME
5-Day
350,822
10-Day
424,511
30-Day
501,490
262,813
  • Prev. Close

    4260.80

  • Open Price

    4275.00

  • Bid Price (Qty.)

    4297.80 (1)

  • Offer Price (Qty.)

    0.00 (0)

Financials

2021 2020 2019 2018 2017
Profit & Loss account of Dr Reddys Laboratories (in Rs. Cr.) Mar 22 Mar 21 Mar 20 Mar 19 Mar 18  
  12 mths 12 mths 12 mths 12 mths 12 mths  
INCOME  
Revenue From Operations [Gross] 14,315.30 13,281.40 11,803.00 10,572.90 9,302.60  
Less: Excise/Sevice Tax/Other Levies 0.00 0.00 0.00 0.00 0.00  
Revenue From Operations [Net] 14,315.30 13,281.40 11,803.00 10,572.90 9,302.60  
Total Operating Revenues 14,405.20 13,349.10 11,850.40 10,625.50 9,359.30  
Other Income 482.00 801.10 743.20 238.40 204.00  
Total Revenue 14,887.20 14,150.20 12,593.60 10,863.90 9,563.30  
EXPENSES  
Cost Of Materials Consumed 3,378.40 3,266.30 2,556.50 2,103.20 2,011.00  
Purchase Of Stock-In Trade 2,057.10 1,252.30 1,117.20 868.60 671.60  
Operating And Direct Expenses 0.00 0.00 0.00 0.00 0.00  
Changes In Inventories Of FG,WIP And Stock-In Trade -389.60 -395.60 -99.90 66.00 -51.60  
Employee Benefit Expenses 2,434.60 2,270.10 2,030.20 1,931.90 1,843.00  
Finance Costs 38.00 46.70 47.80 56.80 62.80  
Depreciation And Amortisation Expenses 814.30 835.00 789.20 780.60 774.10  
Other Expenses 4,320.80 3,804.20 3,376.80 3,356.10 3,555.40  
Total Expenses 12,663.40 11,094.00 9,817.80 9,163.20 8,866.30  
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax 2,223.80 3,056.20 2,775.80 1,700.70 697.00  
Exceptional Items 0.00 0.00 0.00 0.00 0.00  
Profit/Loss Before Tax 2,223.80 3,056.20 2,775.80 1,700.70 697.00  
Tax Expenses-Continued Operations  
Current Tax 392.60 540.10 483.90 281.80 138.10  
Less: MAT Credit Entitlement 0.00 0.00 0.00 0.00 0.00  
Deferred Tax 208.00 329.70 -645.80 141.60 -8.00  
Tax For Earlier Years 0.00 0.00 0.00 0.00 0.00  
Total Tax Expenses 600.60 869.80 -161.90 423.40 130.10  
Profit/Loss After Tax And Before ExtraOrdinary Items 1,623.20 2,186.40 2,937.70 1,277.30 566.90  
Profit/Loss From Continuing Operations 1,623.20 2,186.40 2,937.70 1,277.30 566.90  
Profit/Loss For The Period 1,623.20 2,186.40 2,937.70 1,277.30 566.90  
OTHER ADDITIONAL INFORMATION  
EARNINGS PER SHARE  
Basic EPS (Rs.) 97.85 131.84 177.23 76.98 34.19  
Diluted EPS (Rs.) 97.85 131.46 176.88 76.85 34.12  
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS  
Imported Raw Materials 0.00 0.00 0.00 0.00 0.00  
Indigenous Raw Materials 0.00 0.00 0.00 0.00 0.00  
STORES, SPARES AND LOOSE TOOLS  
Imported Stores And Spares 0.00 0.00 0.00 0.00 0.00  
Indigenous Stores And Spares 0.00 0.00 0.00 0.00 0.00  
DIVIDEND AND DIVIDEND PERCENTAGE  
Equity Share Dividend 414.60 414.70 391.40 332.00 399.20  
Tax On Dividend 0.00 0.00 0.00 68.20 0.00  
Equity Dividend Rate (%) 600.00 500.00 500.00 400.00 400.00  
Source : Dion Global Solutions Limited